Bedtime Versus Morning Dosing of Anti-hypertensives: A GRADE-Assessed Meta-Analysis of Randomized Controlled Trials with Trial Sequential Evidence
- 04.11.2025
- Review article
- Verfasst von
- Mohamed Saad Rakab
- Basel Hatem Elsalakawi
- Abdalhakim Shubietah
- Alaa Maamoun
- Mohab Mattar
- AlMothana Manasrah
- Ubaid Khan
- Ameer Awashra
- Mohammed Ruzieh
- Mohamed Abuelazm
- Erschienen in
- High Blood Pressure & Cardiovascular Prevention
Abstract
Introduction
The timing of anti-hypertensive medication may influence cardiovascular outcomes and blood pressure control, yet the evidence remains inconclusive.
Aim
We conducted a meta-analysis to compare the effects of bedtime versus morning dosing of anti-hypertensives on mortality, cardiovascular events, and ambulatory blood pressure.
Methods
We conducted a meta-analysis of randomized controlled trials (RCTs) comparing bedtime versus morning administration of antihypertensive therapy. A comprehensive literature search was performed in PubMed, Embase, Cochrane Library, Scopus, and Web of Science databases up to June 2025. Pooled risk ratios (RRs) were calculated for categorical outcomes, and mean differences (MDs) for continuous variables. All statistical analyses were performed using R version 4.3.3. PROSPERO registration ID: CRD420251113957.
Results
Pooled analysis of six RCTs with 49,983 patients was included. Bedtime dosing of anti-hypertensive medications resulted in a lower incidence of heart failure (1.3% vs. 2.0%; RR 0.63, 95% CI 0.47–0.85) but not myocardial infarction (1.4% vs. 1.6%; RR 0.87, 95% CI 0.64–1.17), stroke or transient ischemic attack (0.9% vs. 1.3%; RR 0.71, 95% CI 0.49–1.05), all-cause mortality (2.6% vs. 3.1%; RR 0.75, 95% CI 0.53–1.06), or cardiovascular mortality (1.0% vs. 1.5%; RR 0.52, 95% CI 0.22–1.21). For blood pressure, bedtime dosing significantly reduced evening systolic blood pressure (MD − 4.71 mmHg, 95% CI − 6.64 to − 2.78) and evening diastolic blood pressure (MD − 1.66 mmHg, 95% CI − 1.92 to − 1.40), with no significant differences observed in morning readings.
Conclusion
Bedtime administration of anti-hypertensive medications may be associated with reduction in MACE and heart failure incidence. No significant effect was observed in mortality, myocardial infarction, or stroke.
Graphical Abstract
Anzeige
- Titel
- Bedtime Versus Morning Dosing of Anti-hypertensives: A GRADE-Assessed Meta-Analysis of Randomized Controlled Trials with Trial Sequential Evidence
- Verfasst von
-
Mohamed Saad Rakab
Basel Hatem Elsalakawi
Abdalhakim Shubietah
Alaa Maamoun
Mohab Mattar
AlMothana Manasrah
Ubaid Khan
Ameer Awashra
Mohammed Ruzieh
Mohamed Abuelazm
- Publikationsdatum
- 04.11.2025
- Verlag
- Springer International Publishing
- Erschienen in
-
High Blood Pressure & Cardiovascular Prevention
Print ISSN: 1120-9879
Elektronische ISSN: 1179-1985 - DOI
- https://doi.org/10.1007/s40292-025-00755-4
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
